drugset / Trial / NCT00833066
Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether the oral administration of grass pollen peptides is safe and effective in the treatment of allergic rhinitis.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-10
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gpASIT+TM | Peptide | 25 ug | Oral |
| Subject | gpASIT+TM | Peptide | 100 ug | Oral |
| Subject | gpASIT+TM | Peptide | 400 ug | Oral |